Pharmaceutics product development scientists are at the forefront of creating new pharmaceutical formulations that meet both therapeutic goals and patient needs. Their primary responsibility is to design drug products that deliver active pharmaceutical ingredients effectively and safely. This involves selecting the right combination of excipients, optimizing dosage forms, and improving drug stability and bioavailability. They use a variety of formulation techniques to develop products such as tablets, capsules, injectables, and novel delivery systems like transdermal patches or nanoparticle-based carriers. By conducting extensive preformulation and formulation studies, these scientists ensure the drug’s effectiveness while minimizing side effects and maximizing patient compliance.
Moreover, pharmaceutics product development scientists play a critical role in the entire product lifecycle, from initial concept to commercial production. They collaborate with analytical scientists, regulatory experts, and manufacturing teams to ensure that products meet quality standards and regulatory requirements. Their work often includes performing stability testing, compatibility studies, and scale-up processes to ensure that laboratory formulations can be produced consistently on an industrial scale. With ongoing advancements in drug delivery technologies and personalized medicine, these scientists continue to innovate, developing safer, more effective pharmaceutical products that address complex medical challenges and improve global health outcomes. Their contributions are essential to bringing new and improved therapies to patients worldwide.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico